Abstract
Although the efficacy of hormonal replacement therapy (HRT) regarding numerous consequences of menopause is proven, its prevalence of use is low, as is compliance with the prescribed treatment. The aim of this work was to study the factors influencing a woman's decision to take HRT by analyzing the determinants of HRT use of at least 6 months' duration among postmenopausal women working for a French company and enrolled in a cohort study. Special attention was paid to the women's expectations of HRT. we compared two groups of women: 113 current HRT users who had been users for at least 6 months and 101 never users. Among the 113 current users, the most frequent treatment was a combination of oestrogen and progestin (86%). The determinants of HRT use for at least 6 months included a prior spinal radiograph, which showed a significant relationship with the use of hormone treatment (odds ratio (OR) 2.4; 95% confidence interval (CI) 1.2–4.7), a current marriage (OR 2.5; 95% CI 1.3–5.1) and previous hot flushes (OR 2.4; 95% CI 1.2–4.9). The strongest determinant was an expectation that HRT would prevent osteoporosis (or 5.0; 95% CI 2.2–11.6). In this population concern about osteoporosis appears to be an important determinant of HRT use. Our results underline the importance of the diffusion of information among physicians and women about HRT's benefits, especially its efficacy in preventing osteoporosis.
Similar content being viewed by others
References
Ringa V, Ledésert B, Guéguen R, Schiele F, Bréart G. Determinants of hormonal replacement therapy in recently postmenopausal women. Eur J Obstet Gynaecol Reprod Biol 1992;45:193–200.
Barlow DH, Grosset KA, Hart H, Hart DM. A study of the experience of Glasgow women in the climacteric years. Br J Obstet Gynaecol 1989;96:1192–7.
Pedersen SH, Jeune B. Prevalence of hormone replacement therapy in a sample of middle-aged women. Maturitas 1988;9:339–45.
Koster A. Hormone replacement therapy: use patterns among 51-year-old Danish women. Maturitas 1990;345–56.
Spector TD. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. BMJ 1989;299:1434–5.
Consensus development conference, Copenhagen, 14–20 October 1990. Am J Med 1991;90:107–10.
Ravnikar VA. Compliance with hormone therapy. Am J Obstet Gynecol 1987;156:1332–4.
Barret-Connor E, Wingarg DL, Criqui MH. Postmenopausal estrogen use and heart disease risks factors in the 1980s. JAMA 1989;261:2095–100.
Goldberg M, Leclerc A, Chastang JF, Morcet JF, Marne MJ, Luce D, Boumendil E. Mise en place d'une cohorte épidémiologique à Electricité de France-Gaz de France. Recrutement des volontaires. Principales caractéristiques de l'échantillon. Resp-Informations. Rev Epidemiol Sante Publique 1990;38:265–8,378-80.
SAS/STAT User's guide version 6. Cary, N.C.: SAS Institute, 1990.
BMDP statistical software manual. Berkeley, Calif.: University of California Press, 1990.
Jamin C. Evolution du traitement hormonal de la ménopause en France, en Europe. La ménopause au quotidien. Lyon, 1992.
Conférence de consensus: Faut-il médicaliser la ménopause? Rev Fr Gynecol Obstet 1991;4:154–6.
Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438–44.
Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy: a survey of women's knowledge and attitudes. Arch Intern Med 1989;149:133–6.
Draper J, Roland M. Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis. BMJ 1990;300:786–8.
Roberts PJ. The menopause and hormone replacement therapy: views of women in general practice receiving hormone replacement therapy. Br J Gen Pract 1991;41:421–4.
Harris RB, Laws A, Reddy VM, King A, Haskell WL. Are women using postmenopausal estrogens? A community survey. Am J Public Health 1990;80:1266–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ringa, V., Ledésert, B. & Bréart, G. Determinants of hormone replacement therapy among postmenopausal women enrolled in the French GAZEL cohort. Osteoporosis Int 4, 16–20 (1994). https://doi.org/10.1007/BF02352256
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02352256